PGD

Overview

PGD (Phosphogluconate Dehydrogenase) encodes an enzyme in the pentose phosphate pathway. In cancer genomics, PGD has been identified as a GWAS susceptibility locus associated with hepatocellular carcinoma (HCC) risk, particularly in the context of viral hepatitis (HBV/HCV).

Alterations observed in the corpus

• PGD is a GWAS susceptibility locus/SNP associated with HBV- or HCV-related HCC risk PMID:24735922

Cancer types (linked)

Co-occurrence and mutual exclusivity

Therapeutic relevance

Open questions

Sources

• PMID:24735922

This page was processed by entity-page-writer on 2026-05-11.